广东省高年级小学生母亲HPV、HPV疫苗认知及为子女接种意愿现状分析

Analysis of awareness of HPV and HPV vaccine among mothers of senior primary school students in Guangdong province and their willingness to vaccinate their children

摘要

目的 探究广东省高年级小学生母亲的HPV及HPV疫苗认知水平以及为子女接种HPV疫苗接种意愿的影响因素。方法 采用多阶段分层整群抽样方法,于2022年6月至2022年10月在广东省珠三角、东西两翼及粤北地区抽取7所小学,对7所小学五年级和六年级小学生母亲共1262人进行自填式问卷调查,分析高年级小学生母亲对HPV、HPV疫苗的知晓情况以及对子女接种HPV疫苗的态度。结果 共有效调查1168名研究对象,有820(70.21%)名母亲知晓HPV,938(80.31%)名母亲知晓HPV疫苗.高中和大专及以上学历的母亲比初中及以下学历的母亲更可能知晓HPV(高中:OR=2.21,95%CI:1.58~3.10;大专及以上:OR=5.10,95%CI:2.50~10.39)和HPV疫苗(高中:OR=2.18,95%CI:1.47~3.24;大专及以上:OR=9.68,95%CI:3.31~28.25).子女未接种HPV疫苗的母亲中,86.74%母亲愿意为其子女接种HPV疫苗.知晓HPV(OR=1.95,95%CI:1.10~3.46)、知晓HPV疫苗(OR=2.63,95%CI:1.47~4.69)、知晓HPV疫苗相关知识(OR=1.82,95%CI:1.14~2.91)、女孩(OR=2.81,95%CI:1.86~4.26)的母亲为其子女接种HPV疫苗意愿更高。结论 学生性别和HPV及HPV疫苗知晓情况等是影响高年级小学生母亲HPV疫苗接种意愿的主要因素,建议加强高年级小学生母亲人群的HPV疫苗知识健康宣教,提高疫苗接种率,以预防子宫颈癌.

Abstract

Objective To explore the influencing factors of the awareness of HPV and HPV vaccine among mothers of senior primary school students in Guangdong Province and their willingness to vaccinate their children. Methods A self-administered questionnaire survey was conducted on 1262 mothers of fifth- and sixth-grade primary school students in the Pearl River Delta, East and West Wings of Guangdong Province and northern Guangdong Province from June 2022 to October 2022 using the multi-stage stratified cluster sampling method to analyze the mothers' awareness of HPV and HPV vaccine and their attitudes towards HPV vaccination of their children. Results A total of 1168 subjects were effectively investigated, and 820 (70.21%) mothers were aware of HPV and 938 (80.31%) were aware of HPV vaccine. Mothers with high school education or above were more likely to be aware of HPV vaccine (high school: OR=2.21, 95%CI: 1.58-3.10; college degree or above: OR=5.10, 95%CI: 2.50-10.39) and HPV vaccine (high school: OR=2.18, 95%CI: 1.47-3.24; college degree or above: OR=9.68, 95%CI: 3.31-28.25). Among the mothers whose children have not been vaccinated against HPV, 86.74% of mothers are willing to vaccinate their children against HPV. Mothers who knew HPV (OR=1.95, 95%CI: 1.10-3.46), HPV vaccine (OR=2.63, 95%CI: 1.47-4.69), HPV vaccine (OR=1.82, 95%CI: 1.14-2.91), and girls (OR=2.81, 95%CI: 1.86-4.26) were more willing to vaccinate their children. Conclusion Students' gender, HPV and HPV vaccine awareness are the main factors affecting the willingness of mothers of senior primary school students to be vaccinated against HPV, and it is recommended to strengthen the health education of HPV vaccine knowledge among mothers of senior primary school students, and increase the vaccination rate to prevent cervical cancer.

关键词

人乳头瘤病毒 / 人乳头瘤病毒疫苗 / 知晓程度 / 接种意愿 / 子宫颈癌

Key words

human papillomavirus / human papillomavirus vaccine / level of awareness / willingness to vaccinate / cervical cancer

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.

[2] 李宏, 高蓓, 王媛. 1990-2019年我国宫颈癌疾病负担变化趋势分析[J]. 中国慢性病预防与控制, 2022, 30(9): 672-675, 681.

[3] 唐娴, 许晓君, 夏亮, 等. 2012-2016年广东省肿瘤登记地区宫颈癌发病和死亡流行特征分析[J]. 中国肿瘤, 2021, 30(10): 740-745.

[4] Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type[J]. Int J Cancer, 2017, 141(4): 664-670.

[5] Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1): 12-19.

[6] Cheng L, Wang Y, Du J. Human papillomavirus vaccines: an updated review[J]. Vaccines (Basel), 2020, 8(3): 391.

[7] Bosch FX, Robles C, Díaz M, et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer[J]. Nat Rev Clin Oncol, 2016, 13(2): 119-132.

[8] 宋祎凡, 刘晓雪, 尹遵栋, 等. 2018-2020年中国9~45岁女性人乳头瘤病毒疫苗估算接种率[J]. 中国疫苗和免疫, 2021, 27(5): 570-575.

[9] Szilagyi PG, Albertin CS, Gurfinkel D, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US[J]. Vaccine, 2020, 38(38): 6027-6037.

[10] Mihretie GN, Liyeh TM, Ayele AD, et al. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study[J]. Reprod Health, 2022, 19(1): 136.

[11] Chen S, Mei C, Huang W, et al. Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey[J]. BMC Womens Health, 2022, 22(1): 169.

[12] 史金晶, 张肖肖, 郑徽, 等. 中国大陆青少年家长人乳头瘤病毒疫苗认知度和接受度Meta分析[J]. 中国疫苗和免疫, 2019, 25(4): 464-470.

[13] Li J, Li LK, Ma JF, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China[J]. Vaccine, 2009, 27(8): 1210-1215.

[14] Davies C, Stoney T, Hutton H, et al. School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination[J]. Vaccine, 2021, 39(30): 4190-4198.

[15] Ikeda SI, Hineno A, Ozawa K, et al. Suspected adverse effects after human papillomavirus vaccination: a temporal relationship[J]. Immunol Res, 2018, 66(6): 723-725.

[16] 胡熙明, 孙九峰, 赵卫. 亚洲人群HPV疫苗免疫原性及安全性的Meta分析[J]. 中国妇幼健康研究, 2024, 35(1): 58-66.

[17] Drolet M, Bénard É, Pérez N, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis[J]. Lancet (London, England), 2019, 394(10197): 497-509.

[18] Mollborn S, Everett B. Correlates and consequences of parent-teen incongruence in reports of teens' sexual experience[J]. J Sex Res, 2010, 47(4): 314-329.

[19] Wang Z, Wang J, Fang Y, et al. Parental acceptability of HPV vaccination for boys and girls aged 9-13 years in China-a population-based study[J]. Vaccine, 2018, 36(19): 2657-2665.

[20] Santhanes D, Yong CP, Yap YY, et al. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: a systematic review and meta-analysis[J]. Sci Rep, 2018, 8(1): 3640.

基金资助

广东省医学科研基金项目(C2022036)